Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Venous Thromboembolism
Longer endogenous estrogen exposure increases risk of venous thromboembolism
February 16th, 2006
Longer endogenous estrogen exposure increases the risk of venous thromboembolism. According to a study from France, "Lifetime estrogen exposure has been related to breast cancer risk, osteoporosis, and cardiovascular disease but data on venous thromboembolism (VTE) risk are limited." T. Simon and colleagues of INSERM U258 in Villejuif wrote, "Data from a hospital-based case-control study among 608 postmenopausal women (191 with a first episode of idiopathic VTE and 417 age-matched controls) were used to determine whether estrogen exposure, as assessed by age at menopause [classified as early({{<=}}45 years), normal (46-54 years) and late menopause...
Source: Women's Health Weekly (2006-02-16)
|
